##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "32113509.bel"
SET DOCUMENT Authors = "Shounak Baksi"
SET DOCUMENT ContactInfo = "shounak.baksi@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright © 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"

##################################################################################
# NAMESPACES Section
##################################################################################

#DEFINE NAMESPACE ADO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns"
#DEFINE NAMESPACE BRCO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns"
#DEFINE NAMESPACE NIFT AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/nift/NIFT.belns"

DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
#DEFINE NAMESPACE MGI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns"
#DEFINE NAMESPACE RGD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20190128.belns"
#DEFINE NAMESPACE GFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc-gene-families/hgnc-genefamily-names-20181221.belns"
#DEFINE NAMESPACE SCOMP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20190128.belns"
#DEFINE NAMESPACE SFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20190128.belns"
#DEFINE NAMESPACE HP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
DEFINE NAMESPACE DRUGBANK AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns"
#DEFINE NAMESPACE INTERPRO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-names-20181021.belns"
#DEFINE NAMESPACE PFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns"
DEFINE NAMESPACE DO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns"
DEFINE NAMESPACE GO AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns"
#DEFINE NAMESPACE GOBP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20190128.belns"
#DEFINE NAMESPACE GOCC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20190128.belns"
#DEFINE NAMESPACE EFO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/efo/efo-20171206.belns"
DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"
DEFINE NAMESPACE TAX AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
#DEFINE NAMESPACE MESHC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20190128.belns"
#DEFINE NAMESPACE MESHD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20190128.belns"
#DEFINE NAMESPACE MESHPP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20190128.belns"
#DEFINE NAMESPACE MESHA AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-anatomy/mesh-anatomy-20190128.belns"
#DEFINE NAMESPACE MESHCS AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cellular-structures/mesh-cellular-structures-20190128.belns"
#DEFINE NAMESPACE NCBIGENE AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-gene/ncbi-gene-20190224.belns"
#DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"
#DEFINE NAMESPACE UNIPROT AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"
#DEFINE NAMESPACE dbSNP AS PATTERN "rs[0-9]+"
#
#

##################################################################################
# ANNOTATIONS Section
##################################################################################
#DEFINE ANNOTATION Anatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20190128.belanno"
#DEFINE ANNOTATION CellLine AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno"
#DEFINE ANNOTATION Cell AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20190128.belanno"
#DEFINE ANNOTATION Disease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20190128.belanno"
#DEFINE ANNOTATION MeSHAnatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno"
#DEFINE ANNOTATION MeSHDisease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno"
DEFINE ANNOTATION Species AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
#DEFINE ANNOTATION TextLocation AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
#DEFINE ANNOTATION BioAssay AS PATTERN ".*"
DEFINE ANNOTATION Custom_Disease AS LIST {"COVID-19"}
# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Review", "Research", "Commnent"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Preprint", "Published"}
DEFINE ANNOTATION Section AS LIST {"Full Text", "Abstract", "Results"}

##################################################################################
# Statements #
##################################################################################

SET Citation = {"PubMed","Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8.", "32113509"}
SET PublicationType = "Commnent"
SET PublicationStatus = "Published"
SET Section = "Results"
SET Species = "9606"
SET Custom_Disease = "COVID-19"
SET Evidence = "Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterised by an overexuberant inflammatory response and, for SARS, viral load is not correlated with the worsening of symptoms.1,2"

path(DO:"COVID-19") pos path(MESH:Inflammation)
path(DO:"severe acute respiratory syndrome") pos path(MESH:Inflammation)

SET Evidence = "The drug targets are members of the numb-associated kinase (NAK) family—including AAK1 and GAK—the inhibition of which has been shown to reduce viral infection in vitro.5,6 Baricitinib was identified as a NAK inhibitor, with a particularly high affinity for AAK1, a pivotal regulator of clathrinmediated endocytosis. We suggested that this drug could be of use in countering SARS-CoV-2 infections, subject to appropriate clinical testing."

a(DRUGBANK:DB11817) -| p(HGNC:AAK1)
p(HGNC:AAK1) reg bp(GO:"clathrin-dependent endocytosis")
a(DRUGBANK:DB11817) -| a(TAX:"Severe acute respiratory syndrome coronavirus 2")

SET Evidence = "Baricitinib, fedratinib, and ruxolitinib are potent and selective JAK inhibitors approved for indications such as rheumatoid arthritis and myelofibrosis.All three are powerful antiinflammatories that, as JAK–STAT signalling inhibitors, are likely to be effective against the consequences of the elevated levels of cytokines (including interferon-γ) typically observed in people with COVID-19·2"

a(DRUGBANK:DB11817) -| bp(GO:"JAK-STAT cascade")
a(DRUGBANK:DB12500) -| bp(GO:"JAK-STAT cascade")
a(CHEBI:ruxolitinib) -| bp(GO:"JAK-STAT cascade")
a(CHEBI:ruxolitinib) -| p(HGNC:IFNG)
a(DRUGBANK:DB12500) -| p(HGNC:IFNG)
a(DRUGBANK:DB11817) -| p(HGNC:IFNG)
p(HGNC:IFNG) pos path(DO:"COVID-19")

SET Evidence = "Furthermore, there is the potential for combining baricitinib with the directacting antivirals (lopinavir or ritonavir and 121304016) currently being used in the COVID-19 outbreak, since it has a minimal interaction with the relevant CYP drugmetabolising enzymes.Combinations of baricitinib with these direct-acting antivirals could reduce viral infectivity, viral replication, and the aberrant host inflammatory response."

a(CHEBI:lopinavir) -| path(DO:"COVID-19")
a(CHEBI:ritonavir) -| path(DO:"COVID-19")
a(PUBCHEM:121304016) -| path(DO:"COVID-19")
#in CHEBI but not in arti
composite(a(DRUGBANK:DB11817), a(CHEBI:lopinavir)) -| path(DO:"COVID-19")
composite(a(DRUGBANK:DB11817), a(CHEBI:ritonavir)) -| path(DO:"COVID-19")
composite(a(DRUGBANK:DB11817), a(PUBCHEM:121304016)) -| path(DO:"COVID-19")
composite(a(DRUGBANK:DB11817), a(CHEBI:lopinavir)) -| path(MESH:Virulence)
composite(a(DRUGBANK:DB11817), a(CHEBI:ritonavir)) -| path(MESH:Virulence)
composite(a(DRUGBANK:DB11817), a(PUBCHEM:121304016)) -| path(MESH:Virulence)
composite(a(DRUGBANK:DB11817), a(CHEBI:lopinavir)) -| bp(GO:"viral genome replication")
composite(a(DRUGBANK:DB11817), a(CHEBI:ritonavir)) -| bp(GO:"viral genome replication")
composite(a(DRUGBANK:DB11817), a(PUBCHEM:121304016)) -| bp(GO:"viral genome replication")
composite(a(DRUGBANK:DB11817), a(CHEBI:lopinavir)) -| path(MESH:Inflammation)
composite(a(DRUGBANK:DB11817), a(CHEBI:ritonavir)) -| path(MESH:Inflammation)
composite(a(DRUGBANK:DB11817), a(PUBCHEM:121304016)) -| path(MESH:Inflammation)
UNSET Custom_Disease
UNSET Species
UNSET Section
UNSET PublicationStatus
UNSET PublicationType